Neuraxis Q1 2024 GAAP EPS $(0.32) Up From $(1.18) YoY, Sales $646.635K Miss $2.229M Estimate
Portfolio Pulse from Benzinga Newsdesk
Neuraxis (AMEX:NRXS) reported Q1 2024 GAAP EPS of $(0.32), a significant improvement from $(1.18) YoY. However, sales of $646.635K missed the $2.229M estimate by 70.99%, and decreased 19.68% YoY.
May 22, 2024 | 12:10 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Neuraxis reported a significant improvement in GAAP EPS for Q1 2024, but sales missed estimates by a wide margin and decreased YoY.
While the improvement in EPS is positive, the significant miss on sales estimates and the YoY decrease in sales are likely to negatively impact the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100